Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulla Feldt-Rasmussen

Showing results (111-120 of 342) with videos related to

Pageof 35
Sort By:
Plos One|December 3, 2015
Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-UpKirsten Korsholm, Ulla Feldt-Rasmussen, Henrik Granqvist, et al.
JIMD Reports|August 18, 2018
Enzyme Replacement Therapy During Pregnancy in Fabry Patients : Review of Published Cases of Live Births and a New Case of a Severely Affected Female with Fabry Disease and Pre-eclampsia Complicating PregnancyChristoffer V Madsen, Erik Ilsø Christensen, Rikke Nielsen, et al.
Plos One|September 21, 2017
Ghrelin-mediated inhibition of the TSH-stimulated function of differentiated human thyrocytes ex vivoMaria Barington, Marianne Møller Brorson, Jacob Hofman-Bang, et al.
Journal of Diabetes and Its Complications|September 11, 2007
Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetesPeter Clausen, Pia Ekbom, Peter Damm, et al.
European Journal of Endocrinology|June 29, 2002
An audit of the insulin-tolerance test in 255 patients with pituitary diseaseMartin Lange, Ole L Svendsen, Niels E Skakkebaek, et al.
European Journal of Internal Medicine|June 29, 2013
Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itselfStina Dinsen, Bo Baslund, Marianne Klose, et al.
European Journal of Endocrinology|November 8, 2011
Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid AssociationClaudio Marcocci, Torquil Watt, Maria Antonietta Altea, et al.
Hormone Research|December 3, 2003
Thyrotropin-releasing hormone stimulation test in patients with pituitary pathologyMarie-Louise Hartoft-Nielsen, Martin Lange, Ase Krogh Rasmussen, et al.
Pituitary|November 1, 2011
The metabolic consequences of thyroxine replacement in adult hypopituitary patientsHelena Filipsson Nyström, Ulla Feldt-Rasmussen, Ione Kourides, et al.
Journal of Medical Genetics|September 23, 2020
Globotriaosylsphingosine (lyso-Gb<sub>3</sub>) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohortGrigoris Effraimidis, Ulla Feldt-Rasmussen, Åse Krogh Rasmussen, et al.
Pageof 35

Showing results (111-120 of 342) with videos related to

Sort By:
Pageof 35
Plos One|December 3, 2015
Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-UpKirsten Korsholm, Ulla Feldt-Rasmussen, Henrik Granqvist, et al.
JIMD Reports|August 18, 2018
Enzyme Replacement Therapy During Pregnancy in Fabry Patients : Review of Published Cases of Live Births and a New Case of a Severely Affected Female with Fabry Disease and Pre-eclampsia Complicating PregnancyChristoffer V Madsen, Erik Ilsø Christensen, Rikke Nielsen, et al.
Plos One|September 21, 2017
Ghrelin-mediated inhibition of the TSH-stimulated function of differentiated human thyrocytes ex vivoMaria Barington, Marianne Møller Brorson, Jacob Hofman-Bang, et al.
Journal of Diabetes and Its Complications|September 11, 2007
Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetesPeter Clausen, Pia Ekbom, Peter Damm, et al.
European Journal of Endocrinology|June 29, 2002
An audit of the insulin-tolerance test in 255 patients with pituitary diseaseMartin Lange, Ole L Svendsen, Niels E Skakkebaek, et al.
European Journal of Internal Medicine|June 29, 2013
Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itselfStina Dinsen, Bo Baslund, Marianne Klose, et al.
European Journal of Endocrinology|November 8, 2011
Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid AssociationClaudio Marcocci, Torquil Watt, Maria Antonietta Altea, et al.
Hormone Research|December 3, 2003
Thyrotropin-releasing hormone stimulation test in patients with pituitary pathologyMarie-Louise Hartoft-Nielsen, Martin Lange, Ase Krogh Rasmussen, et al.
Pituitary|November 1, 2011
The metabolic consequences of thyroxine replacement in adult hypopituitary patientsHelena Filipsson Nyström, Ulla Feldt-Rasmussen, Ione Kourides, et al.
Journal of Medical Genetics|September 23, 2020
Globotriaosylsphingosine (lyso-Gb<sub>3</sub>) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohortGrigoris Effraimidis, Ulla Feldt-Rasmussen, Åse Krogh Rasmussen, et al.
Pageof 35